MARCO SIRINGO

Dottorando

ciclo: XXXIX
email: marco.siringo@uniroma1.it
telefono: 064462982
edificio: Oncologia Medica, Palazzina ex Scree (PL024) Istituto di Patologia Generale (PL038) Policlinico Umberto I, Viale Regina Elena 324




supervisore: Prof. Daniele Santini
relatore: Prof.ssa Paola Gazzaniga

Ricerca: Il ruolo della biopsia liquida come biomarker nel trattamento del tumore del polmone non a piccole cellule (NSCLC)

Produzione scientifica

  • 11573/1692377 - 2023 - Clinical Utility of Combined Plasma and Tissue NGS in Patients With Newly Diagnosed Advanced Non-Small Cell Lung Cancer (01h Abstract in rivista)
    MARCO SIRINGO
  • 11573/1692559 - 2023 - Circulating CD137+T cells as an immune biomarker for response to anti-PD1 immunotherapy in NSCLC patients (04f Poster)
    ANGELA ASQUINO, FABIO SCIROCCHI, ANGELICA PACE, ILARIA GRAZIA ZIZZARI, MARCO SIRINGO, ELISA TRAMONTANO, Enrico CORTESI, ALAIN JONATHAN GELIBTER, Marianna NUTI, Aurelia RUGHETTI, Chiara NAPOLETANO
  • 11573/1691377 - 2023 - Clinical utility of combined plasma and tissue NGS in patients with advanced, treatment-naïve, Non-small Cell Lung Cancer (01h Abstract in rivista)
    MARCO SIRINGO
  • 11573/1684570 - 2023 - Type 2 diabetes mellitus and efficacy outcomes from imune checkpoint blockade in patients with cancer (01a Articolo in rivista)
    DANIELE SANTINI, RAFFAELE GIUSTI, MARCO FILETTI, FRANCESCA LO BIANCO, PAOLO MARCHETTI, ANDREA BOTTICELLI, ALAIN JONATHAN GELIBTER, MARCO SIRINGO, SERENA MACRINI, federica ZORATTO, LEONARDO BRUNETTI
  • 11573/1692378 - 2023 - Selective Internal Radiation Therapy (SIRT): a new emerging role for Breast Cancer Liver Metastases (01h Abstract in rivista)
    GABRIELLA GENTILE, FRANCESCA SALVATORI, MARCO SIRINGO, SALVATORE CAPONNETTO, Enrico CORTESI
  • 11573/1684569 - 2023 - Evaluation of efficacy of ALK inhibitors according to body mass index in ALK rearranged NSCLC patients—A retrospective observational study (01a Articolo in rivista)
    MARCO SIRINGO, GABRIELLA GENTILE, SALVATORE CAPONNETTO, DANIELE SANTINI, Enrico CORTESI, ALAIN JONATHAN GELIBTER
  • 11573/1692376 - 2023 - Future Perspectives in the Second Line Therapeutic Setting for Non-Oncogene Addicted Non-Small-Cell Lung Cancer (01a Articolo in rivista)
    MARCO SIRINGO
  • 11573/1686455 - 2023 - Comparison between liquid biopsy and tissue NGS in two cohorts of advanced NSCLC (01h Abstract in rivista)
    MARCO SIRINGO
  • 11573/1667503 - 2022 - EP08.02-046 Activity of OsimeRTInib in NSCLC with Uncommon EGFR Mutations: Retrospective Observational Multicenter Study (ARTICUNO) (01h Abstract in rivista)
    MARCO SIRINGO, RAFFAELE GIUSTI, MARCO FILETTI, ALAIN JONATHAN GELIBTER
  • 11573/1678079 - 2022 - Non-small-cell lung cancer: how to manage ALK-, ROS1- and NTRK-rearranged disease (01a Articolo in rivista)
    DANIELE MARINELLI, MARCO SIRINGO, ALAIN JONATHAN GELIBTER
  • 11573/1657288 - 2022 - Advanced non-small-cell lung cancer: how to manage EGFR and HER2 exon 20 insertion mutation-positive disease (01a Articolo in rivista)
    MARCO SIRINGO, DANIELE MARINELLI, ALAIN JONATHAN GELIBTER
  • 11573/1634910 - 2022 - Response to immunotherapy in KRAS G12C mutated NSCLC: a single-centre retrospective observational study (01a Articolo in rivista)
    CAROLINA SCIORTINO, Mariam Grazia Polito, Enrico CORTESI, ALAIN JONATHAN GELIBTER, PAOLA GAZZANIGA, CHIARA NICOLAZZO, MARCO SIRINGO, SALVATORE CAPONNETTO
  • 11573/1603207 - 2021 - PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort (01a Articolo in rivista)
    DANIELE SANTINI, RAFFAELE GIUSTI, MARCO FILETTI, PAOLO MARCHETTI, ANDREA BOTTICELLI, ALAIN JONATHAN GELIBTER, MARCO SIRINGO, SERENA MACRINI
  • 11573/1550733 - 2021 - Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy (01a Articolo in rivista)
    RAFFAELE GIUSTI, ALAIN JONATHAN GELIBTER, MARCO SIRINGO, PAOLO MARCHETTI, MARCO FILETTI
  • 11573/1681943 - 2021 - Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy (01a Articolo in rivista)
    MARCO FILETTI, ALAIN JONATHAN GELIBTER, MARCO SIRINGO
  • 11573/1416319 - 2017 - ADJUVANT TREATMENT IN ELDERLY CANCER PATIENTS: A MULTICENTER REAL-LIFE EXPERIENCE (01a Articolo in rivista)
    MARCO SIRINGO
  • 11573/1681944 - 2017 - Adjuvant treatment in elderly cancer patients: a multicenter real-life experience (01h Abstract in rivista)
    MARCO SIRINGO

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma